Translationally Relevant Oral Ruxolitinib Dosing Reduces Inflammation and Ameliorates Disease in Murine Models of Hemophagocytic Lymphohistiocytosis

Huarte, E; Peel, M; Verbist, K; Fay, B; Albeituni, S; Nichols, KE; Smith, P

BLOOD, 2020; 136 ():